Joint Health Triple Action 560mg/mL Vial CONQUER PHARMA Patients with non-small cell lung

Patients with non-small cell lung cancer or glioblastoma multiforme in two pilot trials received standard therapy plus vitamin C IV

unstable molecules that can damage cells and have been linked to inflammation and a host of age-related diseases from high blood pressure and Alzheimer’s to heart disease and cancer

this cocktail acts at different levels of connective tissue

Edetate disodium also chelates and improves the excretion of other trace metals

Joint Health Triple Action 560mg/mL Vial CONQUER PHARMA Patients with non-small cell lungAdvanced formula for joint regeneration, mobility, and connective tissue support. The Joint Health Cocktail is an advanced injectable solution that combines: Type II Collagen: 20mg mL Glucosamine: 10mg mL Hyaluronic Acid: 1mg mL MSM: 20mg mL Organic Silicon: 2mg mL Zinc: 2mg mL Manganese: 5mg mL Ascorbic Acid: 500mg mL Designed to nourish, protect, and regenerate joints, tendons, and cartilage, this cocktail acts at different levels of connective